Bill Nygren - Oakmark Select Fund
Holding/activity history for Regeneron Pharmaceuticals (REGN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2022 Q2 | 0 | 0 | Sell 100.00% | 3.18 | |
| 2022 Q1 | 224,000 | 3.18 | Reduce 22.76% | 0.94 | $698.42 |
| 2021 Q4 | 290,000 | 3.39 | $631.52 | ||
| 2021 Q3 | 290,000 | 3.52 | Reduce 6.45% | 0.24 | $605.18 |
| 2021 Q2 | 310,000 | 3.42 | Add 1450.00% | 3.20 | $558.54 |
| 2021 Q1 | 20,000 | 0.20 | $473.15 | ||
| 2020 Q4 | 20,000 | 0.24 | Reduce 83.92% | 1.25 | $483.10 |
| 2020 Q3 | 124,400 | 2.10 | Reduce 59.08% | 3.03 | $559.78 |
| 2020 Q2 | 304,000 | 5.44 | Reduce 19.79% | 1.34 | $624.47 |
| 2020 Q1 | 379,000 | 6.11 | Reduce 38.87% | 3.89 | $488.80 |
| 2019 Q4 | 620,000 | 5.04 | $375.48 | ||
| 2019 Q3 | 620,000 | 4.04 | $277.40 | ||
| 2019 Q2 | 620,000 | 4.23 | Add 44.19% | 1.30 | $313.00 |
| 2019 Q1 | 430,000 | 3.90 | Reduce 9.47% | 0.41 | $410.62 |
| 2018 Q4 | 475,000 | 4.28 | Reduce 20.83% | 1.13 | $373.50 |
| 2018 Q3 | 600,000 | 4.20 | $404.04 | ||
| 2018 Q2 | 600,000 | 3.59 | Buy | 3.59 | $344.99 |